Trial
NCT01312389
A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
—
Condition
Ovarian Cancer
Intervention
OC-L/Montanide ISA 51 VG
Why stopped
Did not meet criteria laid out in Phase 1 to continue to Phase 2
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-15